Multiparametric MR Imaging for Detection of Clinically Significant Prostate Cancer: A Validation Cohort Study with Transperineal Template Prostate Mapping as the Reference Standard

Authors:
  • CMCaroline M. Moore
    Caroline M. Moore
  • AFAlex Freeman
    Alex Freeman
  • CAClare Allen
    Clare Allen
  • SSS. Aslam Sohaib
    S. Aslam Sohaib
  • AKAlex Kirkham
    Alex Kirkham
  • JMJan van der Meulen
    Jan van der Meulen
  • MEMark Emberton
    Mark Emberton

Abstract
The combination of an observed negative predictive value of up to 95% for clinically significant prostate cancers (dependent on cancer burden defined on the reference test) and a negative likelihood ratio as low as 0.2 indicates that multiparametric MR imaging may be useful to rule out clinically significant prostate cancer. PurposeTo evaluate the diagnostic performance of multiparametric (MP) magnetic resonance (MR) imaging for prostate cancer detection by using transperineal template prostate mapping (TTPM) biopsies as the reference standard and to determine the potential ability of MP MR imaging to identify clinically significant prostate cancer.Materials and MethodsInstitutional review board exemption was granted by the local research ethics committee for this retrospective study. Included were 64 men (mean age, 62 years [range, 40–76]; mean prostate-specific antigen, 8.2 ng/mL [8.2 μg/L] [range, 2.1–43 ng/mL]), 51 with biopsy-proved cancer and 13 suspected of having clinically significant cancer that was biopsy negative or without prior biopsy. MP MR imaging included T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging (1.5 T, pelvic phased-array coil). Three radiologists independently reviewed images and were blinded to results of biopsy. Two-by-two tables were derived by using sectors of analysis of fo...

This publication has 39 references indexed in Scilit: